News

Portfolio news

Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Acting Oral Products

September 8, 2017

Lyndra, Inc. (Lyndra) announced today a partnership with Allergan plc to develop orally administered ultra-long-acting (once-weekly) products for the treatment of Alzheimer’s disease. The basis of the collaboration between the Boston-based startup and Allergan is Lyndra’s innovative sustained-release technology, which has the potential to transform drugs typically dosed daily to once-weekly oral dosing.

RaNA Therapeutics Relaunches as Translate Bio

June 27, 2017

RaNA Therapeutics today announced the company has relaunched as Translate Bio. Translate Bio is a leading biotechnology company pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases.

Syntimmune Closes $50 Million Series B Financing led by Apple Tree Partners

June 21, 2017

Syntimmune, Inc., a clinical-stage biotechnology company focused on FcRn biology, today announced a $50 million Series B financing led by Apple Tree Partners, which has committed $48 million to the round, with additional participation from other existing investors. The funds from the Series B financing will further advance Syntimmune’s clinical development program.

PHS Spin-off to develop cancer-fighting antibody

May 22, 2017

Fierce Biotech details how MS research at the BWH created an opportunity for PHS spin-off, Tilos, to develop a cancer-fighting antibody.

Partners HealthCare International (PHI) to merge with Partners Innovation

October 13, 2016

On October 1, Partners HealthCare International® (PHI) joined with Partners Innovation. This merger unites a team of more than 110 working to deliver the unique strengths of Partners HealthCare and its faculty to the global markets. PHI was founded in the 1990’s as an arm of Harvard Medical School under the name Harvard Medical International.…

Partners HealthCare and Health Catalyst Honored as Recipients of the 2016 Microsoft Health Innovation Awards

March 9, 2016

SALT LAKE CITY and BOSTON, March 3, 2016 /PRNewswire/ — Health Catalyst and Partners HealthCare today announced they have been named recipients of Microsoft Corp.’s 2016 Health Innovation Awards. The organizations won the “Reinventing Productivity and Business Processes” category, which evaluates solutions that transform care delivery or population health by connecting clinicians and staff to…

Health Catalyst Announces New Products at HIMSS16

March 1, 2016

From the floor of the HIMSS16 Conference and Exhibition in Las Vegas, Health Catalyst announced it is launching the most significant update to its technology and product strategy since the introduction of its industry-changing Late-Binding™ Enterprise Data Warehouse (EDW) in 2008. The expansion of Health Catalyst’s product development program comes with the strong endorsement of…

QPID Acquired by Leading Technology-Enabled Medical Benefit Management Company eviCore healthcare

February 29, 2016

Leading Technology-Enabled Medical Benefit Management Company eviCore healthcare Acquires QPID Health Combined entity will support healthcare’s shift to value-based care with advanced analytics, software and services to support payers, hospitals, physicians and patients BLUFFTON, SC – February 29, 2016 – eviCore healthcare, a company committed to enabling better outcomes for patients, payers and providers through…

Editas Medicine pricing shares at $16 for year’s first IPO: reports

February 3, 2016

Editas Medicine Inc. EDIT, +0.00% priced shares for its initial public offering at the low end of the range, according to media reports late Tuesday, for what will be 2016’s first IPO. Editas will price 5.9 million shares at $16 a share, at the low end of its $16 to $18 range, to raise $94.4…

Partners HealthCare puts millions toward in-house innovation

January 13, 2016

The state’s largest health care system is putting an increased focus on financing homegrown innovations, with Partners HealthCare putting another $65 million in a fund used to invest in Partners technologies while opening the door to outside investors. The Partners Innovation Fund, created in 2007 with $35 million from Partners, was intended to progress Partners-developed…

Partners Innovation Fund Grows to $100 Million

January 12, 2016

Nine years ago, a grand Partners HealthCare experiment was launched. Not on a laboratory bench or in an exam room but on an organization-wide scale. With $35 million at stake, the concept was to run a venture model from within Partners with ready capital and experienced internal venture investors who could steward the creation of…

Cambridge startup Editas plans to test IPO market for biotechs

January 8, 2016

Editas Medicine Inc., a Cambridge startup that is developing treatments to modify disease-causing genetic defects, plans to go public in a deal that could test the strength of the market for new biotech stocks. In a filing Monday with the Securities and Exchange Commission, two-year-old Editas did not specify the sales price range or when…

FierceBiotech’s 2015 Fierce 15

January 8, 2016

Partners Innovation Fund portfolio company and PHS licensee Denali Therapeutics was selected for FierceBiotech’s 2015 highly competitive Fierce 15.

Quartet closes an upsized A round with a novel approach to pain

January 8, 2016

MGH spinout and PIF portfolio company, Quartet Medicine, added $6.25 million to its Series A fundraise, closing the round at $23.25 million as it moves toward clinical trials with a newfangled way of treating chronic pain.

Roche picks up a new autoimmune drug with $580M Adheron deal

January 8, 2016

10-9 – BWH spinout and PIF portfolio company, Adheron, has been acquired by Roch. Adheron is developing antibodies (currently in Phase I) targeting cadherin-11 for treatment of rheumatoid arthritis and other indications, and is based on technology developed by Michael Brenner, MD at BWH. Roche will be a great partner to move the product forward…

Blue Cross Blue Shield invests in Newton medical imaging company lifeIMAGE

January 8, 2016

10-2- PHS spin-off and Partners Innovation Fund portfolio company, lifeIMAGE, announced a $5 million strategic investment from Zaffre Investments, LLC, the investment arm of Blue Cross Blue Shield of Massachusetts. This investment follows the $17.5 million round of financing lifeIMAGE received in May.

FierceBiotech’s 2015 Fierce 15

November 11, 2015

Whatever lies ahead for biotech in 2016, we can now look back on a 3-year-long stretch of good times for the industry. Venture groups have used the wave of biotech IPO exits and M&A deals to go back and raise more money from institutional investors. And as billions of dollars in fresh capital has converged…

Cambridge-based Editas gets $120M investment to advance genome editing

November 11, 2015

Kendall Square startup Editas Medicine, which aims to cure diseases by fixing disease-causing genes, today announced a $120 million investment, representing the second-largest venture capital rounds in Massachusetts so far this year. The Series B round comes from more than a dozen public and private investors, some of which — like New York City-based Deerfield…

GeneInsight wins Bio-IT World’s Best Practice Award

April 10, 2013

Boston—Bio-IT World announced the winners of its ninth Best Practices Awards competition this morning in a plenary session at the 2013 Bio-IT World Conference & Expo in Boston. Grand prize winners were named in four life sciences categories highlighting best practices in genomics, cloud computing, big data in disease research, and big pharma data management…

Special Announcements

Call for Submissions! The Philips Wearables Challenge

August 31, 2017

Call for Submissions! Philips Wearables Challenge  The Philips Wearables Challenge is a call for novel solutions to predict early signs of patient deterioration in order to prevent hospital readmission and escalation in care throughout the patient journey. What cutting edge technologies and systems — wireless wearable sensors, connected devices, continuous, real-time monitoring, data analytics, etc. — can…

$500,000 Partners Innovation Discovery Grant Program: REQUEST FOR APPLICATIONS

August 9, 2017

PARTNERS INNOVATION DEVELOPMENT GRANTS PROGRAM Program Guidelines – 2018 Program Cycle BACKGROUND AND PURPOSE The Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and to increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate commercialization…

Partners HealthCare and GE Healthcare launch 10-year collaboration to integrate Artificial Intelligence into every aspect of the patient journey

May 17, 2017

Partners HealthCare and GE Healthcare today announced a 10-year collaboration to rapidly develop, validate and strategically integrate deep learning technology across the entire continuum of care. The collaboration will be executed through the newly formed Massachusetts General Hospital and Brigham and Women’s Hospital Center for Clinical Data Science and will feature co-located, multidisciplinary teams with…

$1M in New Innovation Discovery Grants

October 13, 2016

Ten projects selected to each receive $100,000 to accelerate patient care Ten Innovation Discovery Grants (IDG) were awarded to support breakthrough technologies. The grants are aimed at improving patient care by accelerating the commercialization of these emerging technologies and efforts to make care delivery more efficient. The IDG program funds prototyping, pre-clinical studies, software development…

Innovation Fellows Program

May 16, 2016

INNOVATION FELLOWS PROGRAM The Innovation Fellows Program is a new initiative that seeks to increase collaboration between the Partners HealthCare community and industry. It is an opportunity for a personnel exchange between PHS core hospitals – Brigham and Women’s Hospital, Massachusetts General Hospital, and McLean Hospital – and participating biopharmaceuticals, venture capital firms, and other…

Partners Event Gathers International Cancer Leaders

March 9, 2016

BOSTON–(BUSINESS WIRE)–Partners HealthCare today announced the second annual World Medical Innovation Forum™, which will bring together more than 1,100 international cancer technology decision-makers from industry, investment, clinical and research communities, April 25-27, 2016 in Boston. “First Look: Next Wave of Cancer Breakthroughs” Tweet this Forum keynoters include the CEOs of Novartis, BMS, Amgen and Abbvie…

INNOVATION IS ON THE MOVE

February 26, 2016

Kendall Square, Cambridge, MA February, 29, 2016 Partners HealthCare Innovation 215 First Street, Suite 500 Cambridge, MA 02142 In February the deal making portion of our team will move to its new home in Kendall Square – the global center of life science discovery and application. The new location will allow us to take direct…

Innovation Discovery Grant

January 22, 2016

PARTNERS INNOVATION DEVELOPMENT GRANTS PROGRAMProgram Guidelines – 2016 Program Cycle BACKGROUND AND PURPOSEThe Innovation Discovery Grants (IDG) program aims to enhance the commercial outcomes of the Partners HealthCare community and to increase its innovative potential. It is designed to stimulate new inventive concepts, identify areas of commercially significant scientific strength, and accelerate commercialization of Partners…

Partners Innovation Development Grants Program

August 25, 2015

Process and Procedures – 2013 Program Cycle Background And Purpose Partners HealthCare (PHS) has established the Innovation Development Grants (IDG) program to significantly enhance the commercial outcomes of the innovations of the outstanding scientists, clinicians and staff of PHS and its affiliated institutions. This new PHS-wide initiative is managed by Research Ventures & Licensing (RVL) and…

Business Development

Sunquest Information Systems and Partners HealthCare Announce New Features to Advance Genome and Exome Testing

October 1, 2015

Release extends filtration, annotation and storage capabilities for complex genetic data Tucson, AZ and Boston, MA —(PRWEB) —  Sunquest Information Systems Inc. and Partners HealthCare today announced the general availability of a new version of GeneInsight, a genetic information solution, to extend the system’s report generation and knowledge management capabilities to exome and genome testing. Developed at…

Partners HealthCare, Health Catalyst announce strategic collaboration to improve patient care

September 10, 2015

Creates new Center of Excellence in Population Health to share best practices, improve patient care BOSTON and SALT LAKE CITY – Partners HealthCare, founded by Brigham and Women’s Hospital and Massachusetts General Hospital, and Health Catalyst have established a strategic collaboration aimed at fostering and accelerating the adoption of population health management (PHM) strategies and…

Partners Innovation Fund

Lyndra, Inc. and Allergan Sign a Partnership to Develop Ultra-Long-Acting Oral Products

September 8, 2017

Lyndra, Inc. (Lyndra) announced today a partnership with Allergan plc to develop orally administered ultra-long-acting (once-weekly) products for the treatment of Alzheimer’s disease. The basis of the collaboration between the Boston-based startup and Allergan is Lyndra’s innovative sustained-release technology, which has the potential to transform drugs typically dosed daily to once-weekly oral dosing.

Sebacia Announces $36 Million Equity and Debt Financing to Advance Breakthrough In-Office Procedure for Acne

August 4, 2017

Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates, Accuitive Medical Ventures and Partners Healthcare Innovation Fund. New investors accounted for approximately 60 percent of the round and include Salem…

RaNA Therapeutics Relaunches as Translate Bio

June 27, 2017

RaNA Therapeutics today announced the company has relaunched as Translate Bio. Translate Bio is a leading biotechnology company pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases.

Syntimmune Closes $50 Million Series B Financing led by Apple Tree Partners

June 21, 2017

Syntimmune, Inc., a clinical-stage biotechnology company focused on FcRn biology, today announced a $50 million Series B financing led by Apple Tree Partners, which has committed $48 million to the round, with additional participation from other existing investors. The funds from the Series B financing will further advance Syntimmune’s clinical development program.

PHS Spin-off to develop cancer-fighting antibody

May 22, 2017

Fierce Biotech details how MS research at the BWH created an opportunity for PHS spin-off, Tilos, to develop a cancer-fighting antibody.

Partners HealthCare and Health Catalyst Honored as Recipients of the 2016 Microsoft Health Innovation Awards

March 9, 2016

SALT LAKE CITY and BOSTON, March 3, 2016 /PRNewswire/ — Health Catalyst and Partners HealthCare today announced they have been named recipients of Microsoft Corp.’s 2016 Health Innovation Awards. The organizations won the “Reinventing Productivity and Business Processes” category, which evaluates solutions that transform care delivery or population health by connecting clinicians and staff to…

Health Catalyst Announces New Products at HIMSS16

March 1, 2016

From the floor of the HIMSS16 Conference and Exhibition in Las Vegas, Health Catalyst announced it is launching the most significant update to its technology and product strategy since the introduction of its industry-changing Late-Binding™ Enterprise Data Warehouse (EDW) in 2008. The expansion of Health Catalyst’s product development program comes with the strong endorsement of…

QPID Acquired by Leading Technology-Enabled Medical Benefit Management Company eviCore healthcare

February 29, 2016

Leading Technology-Enabled Medical Benefit Management Company eviCore healthcare Acquires QPID Health Combined entity will support healthcare’s shift to value-based care with advanced analytics, software and services to support payers, hospitals, physicians and patients BLUFFTON, SC – February 29, 2016 – eviCore healthcare, a company committed to enabling better outcomes for patients, payers and providers through…

Editas Medicine pricing shares at $16 for year’s first IPO: reports

February 3, 2016

Editas Medicine Inc. EDIT, +0.00% priced shares for its initial public offering at the low end of the range, according to media reports late Tuesday, for what will be 2016’s first IPO. Editas will price 5.9 million shares at $16 a share, at the low end of its $16 to $18 range, to raise $94.4…

Spero Therapeutics Announces $30 Million Series B Preferred Financing

February 3, 2016

CAMBRIDGE, Massachusetts, February 2, 2016 – Spero Therapeutics, a biopharmaceutical company founded to develop novel therapies to treat bacterial infections, announced existing Series A investors Atlas Venture, SR One, MRL Ventures, Lundbeckfond Ventures, The Kraft Group and Partners Innovation Fund will provide $30 million in Preferred B funding. Spero will use proceeds from this financing…

NinePoint Medical Receives FDA 510(k) Clearance

November 11, 2015

NinePoint Medical, an in vivo pathology device maker and RVL licensee, recently received 510(k) clearance from the U.S. Food and Drug Administration to market its Nvision VLE Imaging System, a next-generation, high resolution optical imaging technology. The Nvision VLE Imaging System is indicated for use as an imaging tool in the evaluation of human tissue…